How to detect cognitive dysfunction at early stages of multiple sclerosis?

Abstract

Detecting cognitive dysfunction may be clinically important during the early stages of multiple sclerosis (MS). We assessed a self-report questionnaire on cognitive complaints and individual neuropsychological tests to select patients with early relapsing-remitting MS (RRMS) who needed comprehensive cognitive testing.

Fifty-seven patients underwent neurological and neuropsychological assessment, including Rao’s Brief Repeatable Battery (BRB) and the complete SEP-59 Questionnaire, a French adaptation of the MSQOL-54, which contains four specific questions about self-perception of cognitive functions. Predictive values, specificity, sensitivity and accuracy of five individual neuropsychological tests-Selective Reminding Test, Symbol Digit Modalities Test (SDMT), Similarities Subtest, PASAT and Stroop Test-were calculated to predict cognitive impairment.

Only 10.5% of patients did not report any cognitive complaint, while most reported complaints. On the basis of cognitive performances, 59.7% of patients were classified as cognitively impaired, although only one cognitive score was correlated with cognitive complaints. Depressive symptoms and fatigue were associated with more cognitive complaints. Sensitivity of the SDMT to predict cognitive impairment was 74.2%, specificity was 76.9% and accuracy was 75.4%. Since, at this stage, patients’ cognitive complaints are already influenced by depression and fatigue and do not accurately reflect cognitive performances, the SDMT may help to select patients for testing with a more complete cognitive battery.

Keywords

cognition multiple sclerosis relapsing-remitting diagnosis

Get full access to this article

View all access options for this article.

References

Bobholz JA , Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. [Review] . Curr Opin Neurol 2003; 16: 283-288 .

Amato MP , Ponziani G , Pracucci G , Bracco L , Siracusa G , Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up . Arch Neurol 1995; 52: 168-172 .

Rovaris M , Filippi M , Falautano M , Minicucci L , Rocca MA , Martinelli V et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis . Neurology 1998; 50: 1601-1608 .

Deloire MSA , Salort E , Bonnet M , Arimone Y , Boudineau M , Amieva H et al. Cognitive impairment as a marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis . J Neurol Neurosurg Psychiatry 2005; 76: 519-526 .

Krupp LB , Christodoulou C , Melville P , Scherl WF , MacAllister WS , Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial . Neurology 2004; 63: 1579-1585 .

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

Fischer JS , Rudick RA , Cutter GR , Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. [Review] . Mult Scler 1999; 5: 244-250 .

Benedict RH , Munschauer F , Linn R , Miller C , Murphy E , Foley F et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire . Mult Scler 2003; 9: 95-101 .

Benedict RHB , Cox D , Thompson LL , Foley F , Weinstock-Guttman B , Munschauer F. Reliable screening for neuropsychological impairment in multiple sclerosis . Mult Scler 2004; 10: 675-678 .

10.

Zivadinov R , De Masi R , Nasuelli D , Bragadin LM , Ukmar M , Pozzi-Mucelli RS et al. MRI techniques and cognitive impairment in the early phase of relapsingremitting multiple sclerosis . Neuroradiology 2001b; 43: 272-278 .

11.

Vernay D , Gerbaud L , Clavelou P. Quality of life in multiple sclerosis . Rev Neurol (Paris) 2001; 157: 1139-1142 .

12.

Aupperle RL , Beatty WW , Shelton F de N , Gontkovsky ST. Three screening batteries to detect cognitive impairment in multiple sclerosis . Mult Scler 2002; 8: 382-389 .

13.

DeLuca J , Johnson SK , Natelson BH. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis . Arch Neurol 1993; 50: 301-304 .

14.

Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

15.

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey . Neurology 1996; 46: 907-910 .

16.

Montgomery SA , Asberg M. A new depression scale designed to be sensitive to change . Br J Psychiatry 1979; 134: 382-389 .

17.

Sharrack B , Hughes RA. The Guy’s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis . Mult Scler 1999; 5: 223-233 .

18.

Snaith RP , Harrop FM , Newby DA , Teale C. Grade scores of the Montgomery-Asberg depression and the clinical anxiety scales . Br J Psychiatry 1986; 148: 599-601 .

19.

Rao SM. Cognitive Function Study Group , National Multiple Sclerosis Society . A manual for the Brief Repeatable Battery of neuropsychological tests in multiple sclerosis. National Multiple Sclerosis Society , 1990.

20.

Amieva H , Lafont S , Auriacombe S , Le Carret N , Dartigues JF , Orgogozo JM et al.

Inhibitory breakdown and dementia of the Alzheimer type: a general phenomenon?

J Clin Exp Neuropsychol 2002; 24: 503-516 .

21.

Wechsler DA. Manual for the Wechsler Adult Intelligence Scale-revised. The Psychological Corporation , 1981.

22.

Kaplan D , Goodglass A , Weintraub S. Boston naming test. Lea and Febiger , 1983.

23.

Ruff RM. Ruff figural fluency test professional manual. Psychological Assessment Resources Inc. , 1988.

24.

Maor Y , Olmer L , Mozes B. The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients-the role of depression . Mult Scler 2001; 7: 131-135 .

25.

Hoogervorst EL , van Winsen LM , Eikelenboom MJ , Kalkers NF , Uidehaag BM. Comparisons of patients self-report, neurologic examination, and functional impairment in MS . Neurology 2001; 56: 934-937 .

26.

Boringa JB , Lazeron RH , Reuling IE , Ader HJ , Pfennings L , Lindeboom J et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice . Mult Scler 2001; 7: 263-267 .

27.

Bever CT , Grattan L , Panitch HS , Johnson KP. The Brief Repeatable Battery of Neuropsychological Tests for multiple sclerosis: a preliminary serial study . Mult Scler 1995; 1: 165-169 .

28.

Dujardin K , Sockeel P , Cabaret M , De Seze J , Vermersch P. BCogSEP: a French test battery evaluating cognitive function in multiple sclerosis . Rev Neurol (Paris) 2004; 160: 51-62 .

29.

Camp SJ , Stevenson VL , Thompson AJ , Miller DH , Borras C , Auriacombe S et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates . Brain 1999; 122: 1341-1348 .

30.

Randolph JJ , Arnett PA , Higginson CI. Metamemory and tested cognitive functioning in multiple sclerosis . Clin Neuropsychol 2001; 15: 357-368 .

31.

Randolph JJ , Arnett PA , Freske P. Metamemory in multiple sclerosis: exploring affective and executive contributors . Arch Clin Neuropsychol 2004; 19: 259-279 .

32.

Beatty WW , Monson N. Metamemory in multiple sclerosis . J Clin Exp Neuropsychol 1991; 13: 309-327 .